On September 11, 2020, David Hochman submitted his resignation from the Board of Directors of Corbus Pharmaceuticals Holdings, Inc, effective as of September 11, 2020. In so doing, Mr. Hochman also relinquished his positions on the Board’s Finance Committee and Nominating and Corporate Governance Committee. Mr. Hochman’s resignation was not the result of any disagreement with the Company on any matters relating to the Company’s operations, policies or practices.